申请人:——
公开号:US20030022890A1
公开(公告)日:2003-01-30
Novel heterocyclic dihydropyrimidine compounds useful as inhibitors of potassium channel function (especially inhibitors of the K
v
1 subfamily of voltage gated K
+
channels, especially inhibitors K
v
1.5 which has been linked to the ultra-rapidly activating delayed rectifier K
+
current I
Kur
), methods of using such compounds in the prevention and treatment of arrhythmia and I
Kur
-associated conditions, and pharmaceutical compositions containing such compounds.
本发明涉及一种新型杂环二氢嘧啶化合物,其可作为钾通道功能抑制剂(特别是Kv1亚家族电压门控K+通道的抑制剂,特别是与超快速激活延迟整流K+电流IKur相关的Kv1.5的抑制剂),以及使用这些化合物在预防和治疗心律失常和IKur相关疾病方面的方法,以及含有这些化合物的药物组合物。